Panelists discuss how diuretics serve as necessary “bailout therapy” for volume management in heart failure but should not substitute for guideline-directed medical therapy, with emerging evidence ...

CHICAGO — A nasal spray formulation of bumetanide, a diuretic drug, could help treat heart failure by preventing the resistance that can develop to oral forms of the drug, a preliminary safety and ...

Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, demonstrated consistent efficacy and safety regardless of diuretic type or dose and reduced overall diuretic requirements in patients ...

The need to intensify oral diuretic therapy in patients who have heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) is significantly decreased with finerenone (Kerendia; ...

CHICAGO, IL—A novel way of taking the loop diuretic bumetanide—by nasal spray—is safe and well tolerated in healthy adults, according to preliminary randomized data. Diuretic concentrations achieved ...